Daiichi Sankyo (OTCMKTS:DSNKY) Shares Gap Down – Here’s What Happened

by · The Cerbat Gem

Daiichi Sankyo Co., Ltd. – Sponsored ADR (OTCMKTS:DSNKY – Get Free Report) gapped down prior to trading on Wednesday . The stock had previously closed at $22.33, but opened at $21.6960. Daiichi Sankyo shares last traded at $21.4050, with a volume of 56,682 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Zacks Research lowered shares of Daiichi Sankyo from a “hold” rating to a “strong sell” rating in a report on Wednesday, November 19th. One investment analyst has rated the stock with a Strong Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy”.

Get Our Latest Stock Report on DSNKY

Daiichi Sankyo Stock Performance

The company has a current ratio of 2.31, a quick ratio of 1.60 and a debt-to-equity ratio of 0.06. The firm has a market cap of $40.52 billion and a PE ratio of 20.18. The firm has a fifty day moving average price of $22.36 and a 200 day moving average price of $23.72.

About Daiichi Sankyo

(Get Free Report)

Daiichi Sankyo Co, Ltd. is a global, research-driven pharmaceutical company headquartered in Tokyo, Japan. The company was formed through the merger of Daiichi Pharmaceutical and Sankyo in 2005 and focuses on the discovery, development, manufacturing and commercialization of prescription medicines. Its therapeutic priorities include oncology and cardiovascular disease, and it pursues a mix of small molecules, biologics and antibody‑drug conjugates in its development programs.

Daiichi Sankyo is known for building a development portfolio through both internal research and collaborative partnerships.

Further Reading